The analysis revealed that BCL2L1 (BCL-xL) and MCL-1 were exclusively expressed in tumour regions marked by the hallmark chromosomal alterations, namely gain in chromosome 7 and loss of chromosome 10 (Fig. 1D, E). This evidence concerns the gene BCL2L1 and neoplasm.